Intellectual Property,
Civil Litigation
Mar. 25, 2021
Eli Lilly wins patent dispute, loses $10M in fees
While she found Genentech's failure to notify her of a case that weakened its position troubling, U.S. District Judge Janis L. Sammartino rebuffed Eli Lilly's arguments that Genentech improperly initiated and prolonged the litigation despite knowing that it would lose.
Eli Lilly, engaged in a global patent dispute with Genentech over its arthritis drug, lost a bid for $10 million in attorney fees after a federal judge in San Diego rejected claims that it was a victim of bad faith litigation.
While she found troubling Genentech's failure to notify her of a case that weakened its position, U.S. District Judge Janis L. Sammartino rebu...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
